# Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis

> **NCT00480181** · PHASE4 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 50 (estimated)

## Conditions studied

- Neuropathic Pain
- Multiple Sclerosis

## Interventions

- **DRUG:** nabilone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00480181
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2012-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480181, "Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00480181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*